Mostrar el registro sencillo

dc.contributor.authorRamos Valle, Andrés
dc.contributor.authorKirst, Henning 
dc.contributor.authorLópez Fanarraga, Mónica 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-11-20T19:02:03Z
dc.date.available2024-11-20T19:02:03Z
dc.date.issued2024
dc.identifier.issn1071-7544
dc.identifier.issn1521-0464
dc.identifier.urihttps://hdl.handle.net/10902/34494
dc.description.abstractTargeting, safety, scalability, and storage stability of vectors are still challenges in the field of nucleic acid delivery for gene therapy. Silica-based nanoparticles have been widely studied as gene carriers, exhibiting key features such as biocompatibility, simplistic synthesis, and enabling easy surface modifications for targeting. However, the ability of the formulation to incorporate DNA is limited, which restricts the number of DNA molecules that can be incorporated into the particle, thereby reducing gene expression. Here we use polymerase chain reaction (PCR)-generated linear DNA molecules to augment the coding sequences of gene-carrying nanoparticles, thereby maximizing nucleic acid loading and minimizing the size of these nanocarriers. This approach results in a remarkable 16-fold increase in protein expression six days post-transfection in cells transfected with particles carrying the linear DNA compared with particles bearing circular plasmid DNA. The study also showed that the use of linear DNA entrapped in DNA@SiO₂ resulted in a much more efficient level of gene expression compared to standard transfection reagents. The system developed in this study features simplicity, scalability, and increased transfection efficiency and gene expression over existing approaches, enabled by improved embedment capabilities for linear DNA, compared to conventional methods such as lipids or polymers, which generally show greater transfection efficiency with plasmid DNA. Therefore, this novel methodology can find applications not only in gene therapy but also in research settings for high-throughput gene expression screenings.es_ES
dc.description.sponsorshipFunding: MLF acknowledges the financial support from the Spanish Instituto de Salud Carlos iii, and the European Union FEDER funds under Projects ref. PI22/00030, co-funded by the European Regional Development Fund, ‘Investing in your future’ and Grant TED2021-129248B-100, the Maria Zambrano Fellowship RMZ-015 funded by MCIN/AEI/10.13039/ 501100011033 and by the ‘European Union Next Generation EU/PRTR.’ We also thank the Gobierno Regional de Cantabria and IDIVAL for the project Refs IDI 20/22, INNVAL21/19, NEXTVAL 22/12, and IDI-020-022. The figures and graphs have been created with BioRender software (BioRender.com, License ID: 9519A1C8-0002).es_ES
dc.format.extent10 p.es_ES
dc.language.isoenges_ES
dc.publisherTaylor & Francises_ES
dc.rights© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceDrug Delivery, 2024, 31(1), 2385376es_ES
dc.subject.otherStöber methodes_ES
dc.subject.otherSilica nanoparticleses_ES
dc.subject.otherGene delivery DNA embedmentes_ES
dc.subject.otherGene transfectiones_ES
dc.titleBiodegradable silica nanoparticles for efficient linear DNA gene deliveryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1080/10717544.2024.2385376es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1080/10717544.2024.2385376
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.